Implicity Remote Monitoring:
Simple Automation,
Big Impact
Implicity’s AI-driven solutions revolutionise healthcare, enabling physicians, administrators, clinic staff, and IT professionals to deliver faster, smarter, and more personalized care. Designed by an Electrophysiologist, Implicity tackles the real challenges of daily clinical practice.


Implicity Remote Monitoring: Associated with Reduced Mortality, Hospitalisation Rates
During this year’s Heart Rhythm Society, Professor Niraj Varma presented a Late Breaking Abstract titled “Clinical impact of a universal remote monitoring platform for ICD and CRT-D follow-up from a large real-world registry.” The abstract highlighted that the Implicity remote cardiac monitoring platform is associated with reduced mortality by 22% and reduced hospitalisation by 4% vs. conventional remote monitoring.
These impressive results support the recent expert consensus statement released by HRS/EHRA/APHRS/LAHRS during this year’s annual Heart Rhythm Scientific Program in New Orleans on the “Practical Management of the Remote Device Clinic” which highlights in detail the importance of third-party resources for remote monitoring efficiency.
Selected References
- Durand J, et al. Using Technology to Improve Reconnection to Remote Monitoring in Cardiac Implantable Electronic Device Patients. Cardiovascular Digital Health Journal. Published November 23, 2023.
- IM009 (2021). Manufacturer: Implicity. IM009 is a software as a medical device (SaMD) intended for use as an adjunct to a remote monitoring platform for follow-up of target patient populations. IM009 is not approved for use in Australia.
- Ganji J, MD, FACC. Piedmont Cardiovascular. November 2022.
Can’t find what you are looking for? Visit www.implicity.com.
Regulatory approval requirements vary by region. Contact Hydrix to learn more.

